CEU Courses

Migraine is a common neurological disorder with audiovestibular symptoms like tinnitus, hearing loss, and vertigo, requiring audiologists to understand its management. This webinar covers migraine mechanisms, management strategies, and their connection to ear disorders, providing practical information for clinical practice.

This presentation reviews some of the medications that may lead to balance conditions and the risk of falling. The speaker will discuss drug classifications that may directly harm the vestibular system, and the myriad of medications that have dizziness, fall risk, and vertigo as prevalent adverse effects. In addition, the session will describe types of vestibular testing that may be done to better evaluate and treat these conditions in affected patients.

This course presents candidacy considerations for the selection of middle ear implants; methods of delivering the acoustic signal to the patient through middle ear implant technology; current and developing middle ear implant technology; and the benefits and limitations of current middle ear technology.

This course utilizes a case-history format to educate attendees on evaluating and managing patients presenting with facial nerve paralysis. Considerations for audiological assessment will be reviewed.

An overview of mild traumatic brain injury (mTBI)/concussion and its pathophysiology, with particular emphasis on diagnostic and rehabilitation tools utilized by SLPs and audiologists, is provided in this course. Impacts of mTBI on hearing, cognition, vision and the vestibular system, assessments performed by the two disciplines post-concussion, and treatments for cognition (including auditory processing disorder) are described.

This course discusses various otologic diseases and how audiologists can participate in the care.

This course reviews conductive hearing loss amplification needs and management options. We explore the offerings of the Cochlear Osia 2 device and compare to other bone anchored hearing devices.

This course analyzes current barriers hindering the consistent implementation of effective ototoxicity monitoring programs in the clinical setting. This course also highlights various ways these barriers were able to be addressed and successfully implemented by showcasing existing data.

This course focuses on cases that incorporate aspects of medical audiology and considerations for audiologists providing patient care in this population.

This article details the latest developments in the field of auditory biotechnologies that aim to medically treat hearing loss using a series of different approaches. The biotechnologies described in this interview include both restorative and protective treatments, and some of the molecular and cellular mechanisms behind these treatments are described along with the most likely patient populations for early clinical trials. Finally, the current state of offerings for auditory biotechnologies is also reviewed, and readers are pointed to appropriate information to connect their patients to upcoming clinical trials.